Frontiers in Immunology (Dec 2019)
Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
- Rafijul Bari,
- Markus Granzin,
- Kam Sze Tsang,
- Andre Roy,
- Winfried Krueger,
- Rimas Orentas,
- Dina Schneider,
- Rita Pfeifer,
- Nina Moeker,
- Els Verhoeyen,
- Els Verhoeyen,
- Boro Dropulic,
- Wing Leung
Affiliations
- Rafijul Bari
- Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States
- Markus Granzin
- Miltenyi Biotec Inc, Gaithersburg, MD, United States
- Kam Sze Tsang
- Miltenyi Biotec Inc, Gaithersburg, MD, United States
- Andre Roy
- Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States
- Winfried Krueger
- Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States
- Rimas Orentas
- Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States
- Dina Schneider
- Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States
- Rita Pfeifer
- Miltenyi Biotec, Bergisch Gladbach, Germany
- Nina Moeker
- Miltenyi Biotec, Bergisch Gladbach, Germany
- Els Verhoeyen
- CIRI, Université de Lyon 1, INSERM U1111, CNRS UMR 5308, ENS de Lyon, Lyon, France
- Els Verhoeyen
- Université Côte d'Azur, INSERM U1065, C3M, Nice, France
- Boro Dropulic
- Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States
- Wing Leung
- Miltenyi Biotec Inc, Gaithersburg, MD, United States
- DOI
- https://doi.org/10.3389/fimmu.2019.02784
- Journal volume & issue
-
Vol. 10
Abstract
No abstracts available.Keywords
